NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer

Payton De La Cruz,Julia McAdams,Melanie Morales Aquino,Aileen I. Fernandez,Andrew Elliott,Maryam Lustberg,Christoph Schorl,Jennifer R. Ribeiro,Nicole E. James

DOI: https://doi.org/10.1186/s13058-024-01925-3

2024-12-05

Breast Cancer Research

Abstract:Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. While PD-1 based immunotherapies overall have led to improved treatment outcomes for this disease, a diverse response to frontline chemotherapy and immunotherapy still exist in TNBC, highlighting the need for more robust prognostic markers.

oncology